Utah Medical Products
UTMD
92 hedge funds and large institutions have $285M invested in Utah Medical Products in 2018 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 32 increasing their positions, 25 reducing their positions, and 2 closing their positions.
550% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 2
28% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 25
14% more funds holding
Funds holding: 81 → 92 (+11)
3% more capital inflows, than outflows
Capital inflows: $19.6M | Capital outflows: $19M
0.02% more ownership
Funds ownership: 69.32% → 69.34% (+0.02%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ranger Investment Management
Dallas,
Texas
|
+$2.68M |
| 2 |
Lazard Asset Management
New York
|
+$2.66M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.62M |
| 4 |
BlackRock
New York
|
+$1.76M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$1.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WCM Investment Management
Laguna Beach,
California
|
-$8.07M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.38M |
| 3 |
Russell Investments Group
London,
United Kingdom
|
-$1.31M |
| 4 |
Ancora Advisors
Cleveland,
Ohio
|
-$1.27M |
| 5 |
Clean Yield Group
Norwich,
Vermont
|
-$1.06M |
UTMD Hedge Fund Activity: Q2 2018 in Review
92 of the 4,386 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q2 2018, worth a combined $285M — up 11% from $256M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new UTMD positions and 2 closed out — a net gain of 11 holders — while 32 added to existing stakes and 25 trimmed.
The largest buyer was Ranger Investment Management, opening a new position worth an estimated $2.68M. The largest seller was WCM Investment Management, exiting entirely with an estimated $8.07M sold.
- 92 institutional investors held Utah Medical Products (UTMD) as of Q2 2018, up from 81 in Q1 2018.
- Funds reported $285M of Utah Medical Products stock for Q2 2018, up 11% quarter-over-quarter.
- 13 funds opened new Utah Medical Products positions in Q2 2018 and 2 closed out, a net change of +11 holders.
- The largest Utah Medical Products buyer in Q2 2018 was Ranger Investment Management, an estimated $2.68M added.
- The largest Utah Medical Products seller in Q2 2018 was WCM Investment Management, an estimated $8.07M sold.
Based on aggregated 13F filings for Q2 2018.